Latest Germany News

Neuren Pharmaceuticals saw a record Q2 with DAYBUE net sales hitting US$125 million, driven by strong uptake of the new STIX formulation. The company upgraded its 2026 royalty guidance following Acadia Pharmaceuticals’ sales boost and awaits key regulatory milestones in Europe and Japan.

GreenX Metals has expanded its Eleonore North Project with two new licences covering about 1,600 km² in East Greenland, targeting intrusion-related gold and critical minerals like tungsten. Historical data shows high gold grades up to 50 g/t, with fieldwork results due this quarter.

ClearVue Technologies has developed a unique manufacturing capability allowing its Gen 3 Vision Glass to have soft high-performance Low-E coatings applied on surface 4, the optimal position for solar heat control, after photovoltaic cells are laminated. This breakthrough enhances thermal performance and expands commercial façade market access globally.

Cosmos Exploration has completed its merger with EAU Lithium, securing key partnerships and technology to progress lithium development in Bolivia. The company also committed to acquiring a German-built pilot plant to support its VULSORB® extraction technology.

GreenX Metals has outlined a substantial Exploration Target at its Tannenberg Copper Project in Germany, confirming its geological similarity to major Polish Kupferschiefer mines and setting the stage for active drilling and metallurgical work. Concurrently, fieldwork at the Eleonore North Project in Greenland has identified new high-priority tungsten and antimony targets, while a key legal challenge in Singapore was dismissed, affirming GreenX’s compensation rights.

Talga Group has marked a milestone with its first commercial delivery of natural graphite anode outside Asia, progressing key funding discussions and strategic partnerships to support its Vittangi Anode Project.

Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.

Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.

BLS Pharmaceuticals capped FY2026 with record quarterly revenue and operating cash flow, driven by international expansion and new supply agreements across regulated markets.

Vulcan Energy Resources has reached financial close on its €2.2 billion Lionheart Project financing, unlocking funds and accelerating construction across its integrated lithium and renewable energy facilities in Germany.

Element 25 is on track to commission its Butcherbird manganese expansion in early 2027, while securing a substantial US Department of Energy grant to support its US battery materials facility.

Wide Open Agriculture (ASX: WOA) is executing a major strategic pivot by closing its German production site and transitioning to a capital-light contract manufacturing model to improve economics and scale lupin protein production.